Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.
Kastritis E, Gavriatopoulou M, Kyrtsonis MC, Roussou M, Hadjiharissi E, Symeonidis A, Repoussis P, Michalis E, Delimpasi S, Tsatalas K, Tsirigotis P, Vassou A, Vervessou E, Katodritou E, Gika D, Terpos E, Dimopoulos MA.
Kastritis E, et al. Among authors: roussou m.
Blood. 2015 Sep 10;126(11):1392-4. doi: 10.1182/blood-2015-05-647420.
Blood. 2015.
PMID: 26359434
Free article.
Clinical Trial.
No abstract available.